Skip to main content

Financial News

  • McKesson declares quarterly dividend

    SAN FRANCISCO McKesson on Friday announced that its board of directors approved a quarterly dividend of 18 cents per share.

    The dividend is payable on Jan. 3, 2011, to stockholders of record on Dec. 1, 2010, the healthcare and drug distribution company said.

    Earlier this week, McKesson reported that its revenues rose nearly 1.5% to $27.5 billion for the quarter ended Sept. 30, compared with the year-ago period.

  • Q3 slips for Revlon, but company looks forward to future

    NEW YORK Beauty company Revlon announced on Thursday a 2.2% dip in net sales as net income narrowed during the third quarter, but executives remained optimistic as the manufacturer gears up for 2011 with a new global chief marketing officer in place.

  • Oral care innovations help drive Colgate-Palmolive's quarterly earnings

    NEW YORK Colgate-Palmolive experienced a strong third quarter as its global market shares in toothpaste and manual toothbrushes reached record highs year-to-date, the company announced on Thursday.

    "Overall, we are very pleased with our solid results this quarter, despite aggressive competitive activity and difficult economic conditions around the world," stated Ian Cook, chairman, president and CEO. 

  • Strong sales boost Mylan's Q3

    PITTSBURGH Sales and profits have increased at Mylan during the third quarter and over the year, the generic drug maker said in an earnings report Tuesday.

    Mylan said sales for the quarter ended Sept. 30 were $1.36 billion, with gross profits of $580.1 million. Sales and profits for the same period last year were $1.26 billion and $505 million, respectively. Sales and gross profit for the first nine months of the year were $4.02 billion and $1.64 billion, compared with $3.74 billion and $1.56 billion last year.

     

  • P&G's CEO on Q1 results: 'Purpose-inspired growth strategy' is working

    CINCINNATI Procter & Gamble announced on Wednesday that first-quarter earnings per share from continuing operations exceeded estimates and rose 5% as net sales rose 2% to $20.1 billion.

X
This ad will auto-close in 10 seconds